The Therapeutic Potential of Melatonin in Neurological Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|3|1|60-64

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.3, Iss.1, 2009-01, pp. : 60-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relevance of the Chronobiological and Non-chronobiological Actions of Melatonin for Enhancing Therapeutic Efficacy in Neurodegenerative Disorders

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 2, 2011-05 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin Effects on Plasmodium Life Cycle: New Avenues for Therapeutic Approach

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 139-147

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Utilisations of Vasopressin and Oxytocin in Mood Disorders

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 157-161

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Natural Products in Parkinson's Disease

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 3, 2012-09 ,pp. : 181-200

Bentham Science Publishers

Access to resources Recommend Favorite